Möchten Sie immer auf dem neuesten Stand bleiben?

Kraig Labs (OTCQB: KBLB) is entering a new phase of commercial scale-up as it accelerates spider silk production to meet growing demand from global brands.

Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programs Vispa-cel (CB-010) ANTLER phase 1 translational and clinical data...

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Market" has been added to ResearchAndMarkets.com's offering. The gene therapy market is forecasted to expand significantly, with a...

Vispa-cel (CB-010) ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for outpatient use, highlighting its potential as a best-in-class...

Austin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Phosphoramidite Market Size & Growth Analysis According to SNS Insider, the global Phosphoramidite Market was valued at USD 1.18 billion in 2024 and is...

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...

San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics, today announced that its founding discovery...

New York, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight CRISPR therapies offer...

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Global Biochemicals Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The global biochemicals market represents one of...